Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 9/20 | 1.00 |
| ▸ | CCNE2 | O96020 | 8/20 | 1.00 |
| ▸ | CCNE1 | P24864 | 8/20 | 1.00 |
| ▸ | CDK2 | P24941 | 8/20 | 1.00 |
| ▸ | ATR | Q13535 | 11/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | GSK3A | P49840 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6035742 | 0.99 | GSK3B (0.98) | GSK3BCCNE2CCNE1CDK2ATR | |
| SCHEMBL6034278 | 0.95 | GSK3B (0.90) | GSK3BCCNE2CCNE1CDK2ATR | |
| SCHEMBL6034146 | 0.91 | GSK3B (0.84) | GSK3BCCNE2CCNE1CDK2ATR | |
| SCHEMBL2483383 | 0.91 | ATR (1.00) | GSK3BCCNE2CCNE1CDK2ATR | |
| SCHEMBL6034005 | 0.87 | CCNE2 (0.77) | GSK3BCCNE2CCNE1CDK2ATR | |
| SCHEMBL6034567 | 0.86 | GSK3B (0.75) | GSK3BCCNE2CCNE1CDK2ATR | |
| Hydrochloric Acid SCHEMBL6597556 | 0.85 | GSK3B (0.74) | GSK3BCCNE2CCNE1CDK2ATR | |
| Hydrochloric Acid SCHEMBL6033864 | 0.84 | GSK3B (0.72) | GSK3BCCNE2CCNE1CDK2ATR | |
| SCHEMBL6616717 | 0.82 | ATR (0.82) | GSK3BCCNE2CCNE1CDK2ATR | |
| SCHEMBL3162088 | 0.82 | ATR (0.81) | GSK3BCCNE2CCNE1CDK2ATR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1414801-A1 | ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 | AstraZeneca AB (SE) | 2004-05-06 | — | — | EP | claimed |
| WO-2003004472-A1 | ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 | ASTRAZENECA AB (SE) | 2003-01-16 | — | — | WO | claimed |
| EP-1414801-A1 | ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 | AstraZeneca AB (SE) | 2004-05-06 | — | — | EP | disclosed |
| WO-2003004472-A1 | ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 | ASTRAZENECA AB (SE) | 2003-01-16 | — | — | WO | disclosed |